ID   BMA3.1A7
AC   CVCL_IW58
SY   BM A3.1A7; BMA; A3.1A7
DR   ABM; T0673
DR   Wikidata; Q54797535
RX   DOI=10.4172/2155-9899.1000318;
RX   PubMed=7809629;
RX   PubMed=7925570;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IW57 ! BMA3.1A
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 6
//
RX   DOI=10.4172/2155-9899.1000318;
RA   Banete A., Achita P., Harding K., Mulder R., Basta S.;
RT   "Immortalized murine macrophage cell line as a model for macrophage
RT   polarization into classically activated M(IFNgamma+LPS) or alternatively
RT   activated M(IL-4) macrophages.";
RL   J. Clin. Cell. Immunol. 6:318-318(2015).
//
RX   PubMed=7809629; DOI=10.1126/science.7809629;
RA   Kovacsovics-Bankowski M., Rock K.L.;
RT   "A phagosome-to-cytosol pathway for exogenous antigens presented on
RT   MHC class I molecules.";
RL   Science 267:243-246(1995).
//
RX   PubMed=7925570; DOI=10.1002/eji.1830241024;
RA   Kovacsovics-Bankowski M., Rock K.L.;
RT   "Presentation of exogenous antigens by macrophages: analysis of major
RT   histocompatibility complex class I and II presentation and regulation
RT   by cytokines.";
RL   Eur. J. Immunol. 24:2421-2428(1994).
//